Showing results (1-10 of 278) with videos related to
Sort By:
Pageof 28
Nature Reviews. Clinical Oncology|February 22, 2012
Hurdles in anticancer drug development from a regulatory perspectiveBertil Jonsson, Jonas BerghMedical Oncology (Northwood, London, England)|September 18, 2007
Erythropoietin therapy and cancer related anaemia: updated Swedish recommendationsJane Ahlqvist-Rastad, Maria Albertsson, Jonas Bergh, et al.Breast (Edinburgh, Scotland)|December 9, 2003
Best use of adjuvant systemic therapies II, chemotherapy aspects: dose of chemotherapy-cytotoxicity, duration and responsivenessJonas BerghBreast (Edinburgh, Scotland)|October 26, 2005
Adjuvant chemotherapy for breast cancer--"one fits all"?Jonas BerghTraffic Injury Prevention|December 6, 2008
Backset-stationary and during car drivingBertil Jonsson, Hans Stenlund, Ulf BjörnstigBMC Cancer|July 23, 2011
A simple method for assigning genomic grade to individual breast tumoursKristian Wennmalm, Jonas BerghActa Obstetricia Et Gynecologica Scandinavica|November 20, 2023
Breast cancer during pregnancy-The oncologist's point of viewAlexios Matikas, Jonas BerghMolecular Oncology|December 8, 2014
Assessment of benefits and risks in development of targeted therapies for cancer--The view of regulatory authoritiesFrancesco Pignatti, Bertil Jonsson, Gideon Blumenthal, et al.Chinese Clinical Oncology|April 6, 2015
The changing world of cancer drug development: the regulatory bodies' perspectiveIordanis Gravanis, Camille Vleminckx, Bertil Jonsson, et al.Pageof 28